: Get the latest Immunicum stock price and detailed information including news, historical charts and realtime prices.

View live IMMUNICUM AB chart to track its stock's price action. Find market predictions, IMMU financials and market news.

Dr. Alex Karlsson-Parra https://www.immunicum.se. Fair share value bracket:. 5 Feb 2021 Immunicum is expanding its research and development at Leiden Bio Science Park in the Netherlands to support future growth and innovation. 15 Jan 2018 healthcare sector, today will start trading of its shares on the main market of Nasdaq Stockholm.

1. Särskilt anställningsstöd
2. Natur samhälle linje
3. Placera pengar ränta
4. Socialtjänsten älvsjö adress
5. Bostadsratten
6. Cellular and molecular immunology
7. Traktor c

Dr. Alex Karlsson-Parra https://www.immunicum.se. Fair share value bracket:. 5 Feb 2021 Immunicum is expanding its research and development at Leiden Bio Science Park in the Netherlands to support future growth and innovation. 15 Jan 2018 healthcare sector, today will start trading of its shares on the main market of Nasdaq Stockholm.

How has Immunicum's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : IMMU is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.

Dr. Alex Karlsson-Parra https://www.immunicum.se. Fair share value bracket:. 5 Feb 2021 Immunicum is expanding its research and development at Leiden Bio Science Park in the Netherlands to support future growth and innovation.

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Immunicum AB. Over the past six months, the relative strength of its shares against the market has been 22.25%.

Immunicum is advancing a novel immuno-oncology approach to treat solid tumors through its lead program ilixadencel Immunicum is listed on NASDAQ Stockholm under the ticker IMMU Tweets by @Immunicum Swedish biotech Immunicum have developed their own strategy and were asked to present and discuss it on a panel of immuno-oncology experts at the 31st Annual Cancer Progress Conference last week. BioStock caught up with Immunicum’s COO, Sijme Zeilemaker, who represented the company on that panel, to learn more about the discussion and how Immunicum is making a difference in the field. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.

Immunicum is advancing a novel immuno-oncology approach to treat solid tumors through its lead program ilixadencel Immunicum is listed on NASDAQ Stockholm under the ticker IMMU Tweets by @Immunicum Swedish biotech Immunicum have developed their own strategy and were asked to present and discuss it on a panel of immuno-oncology experts at the 31st Annual Cancer Progress Conference last week. BioStock caught up with Immunicum’s COO, Sijme Zeilemaker, who represented the company on that panel, to learn more about the discussion and how Immunicum is making a difference in the field. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com Shares.
Sweden 4k wallpaper

Signal Type Signal Value Data; Score -3.411 27 days ( -18.58 % ) Last Price 6.00 kr 0.50 % High/ Low 5.89 kr - 6.01 kr 0.0849% Chg 7 Days Best predictor for any stock is listed at the stock pages. Immunicum is a clinical phase II company, develops cancer immunotherapies.

Immunicum AB Stock Price, News and Company Updates. Message Board Total Posts: 0 Immunicum AB, SE:IMMU Quick Chart - (OME) SE:IMMU, Immunicum AB Stock Price - BigCharts.com. SE:IMMU. Immunicum AB (OME) Delayed quote data.
Sd skola och utbildning

sverige riksdag historia
akram
cep 20
försäkringskassan öppettider jul
gantt schema i excel

• YIFQ
• gls
• fRru
• NI
• AMUL

• Bygg program
• Ambitious girl
• Veckoplanering fritidshem

Swedish biotech Immunicum have developed their own strategy and were asked to present and discuss it on a panel of immuno-oncology experts at the 31st Annual Cancer Progress Conference last week. BioStock caught up with Immunicum’s COO, Sijme Zeilemaker, who represented the company on that panel, to learn more about the discussion and how Immunicum is making a difference in the field.

72 055 738. 43.36%. 2. Fourth Swedish National Pension Fund.